Stephen I. Pelton, MD

Pediatric I D physician
Boston Medical Center

Disclosure: Merck vaccine (Consultant, Grant/Research Support)Pfizer (Consultant, Grant/Research Support)Sanofi Pasteur (Consultant, Other Financial or Material Support, DSMB)Seqirus Vaccine Ltd. (Consultant)

I am Stephen I Pelton, MD. Professor of Pediatrics at Boston University School of Medicine and Senior Attending in Pediatric Infectious Diseases at Boston Medical Center. I am Director of Maternal-Child HIV at Boston Medical Center. The focus of my research is vaccine preventable diseases, specifically Streptococcus pneumoniae, Neisseria meningitis, and nontypable Haemophilus influenzae.

Poster(s):

14 - A Comprehensive Real-World Analysis to Compare Adjuvanted Trivalent Influenza Vaccine and Trivalent High Dose Influenza Vaccine by Age and Period of High Influenza Activity for the 2018-19 Season among U.S. Elderly
29 - Impact of Enhanced Influenza Vaccines on Direct Healthcare Costs for the U.S. Elderly: A Comprehensive Real-World Evaluation of Adjuvanted Trivalent Influenza Vaccine Compared to Trivalent High-Dose Influenza Vaccine for the 2018-19 Influenza Season
1404 - Twenty-year impact of Pneumococcal Conjugate Vaccines (PCV) on the burden of invasive pneumococcal disease in US children less than 5 years of age
1510 - Infant Pneumonia and Subsequent Risk of Chronic Respiratory Disorders
1514 - Mortality and Readmission in Adults during the First Year Following Hospitalization for Community-Acquired Pneumonia in the US